BCTX

Briacell Therapeutics
BCTX

11.39 USD
-0.85
6.94%
At close Updated Dec 5, 4:00 PM EST
Pre-market
After hours
11.65
+0.26
2.28%
1 day
-6.94%
5 days
23.14%
1 month
11.45%
3 months
44.73%
6 months
-65.9%
Year to date
-86.91%
1 year
-92.48%
5 years
-98.05%
10 years
-98.05%
 

About: BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Employees: 4

Healthcare Biotechnology
0
Funds holding %
of 7,499 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
0
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™